Pharma Fusion announces it has entered into a Strategic Merger Agreement with Santa Rosa Pharmacy, uniting two specialty pharmacy leaders under a single, patient-centered platform. The combined integration creates a scaled, national specialty pharmacy with deep clinical expertise in bleeding disorders, immunoglobulin (Ig) therapies, and hereditary angioedema (HAE), designed to deliver high-touch care for patients living with complex and rare disorders with expensive biological therapies. Combined, the new Pharma Fusion is projected to generate revenues of more than $130 million in 2026.
Read the full article: Pharma Fusion and Santa Rosa to Merge //
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/pharma-fusion-and-santa-rosa-merger-1154042